Inventor · disambiguated record
Matthew Lucas Eaton
Also filed as: EATON MATTHEW L · EATON MATTHEW LUCAS
7 granted patents·3 pending applications·19 citations·filing 2016–2023
82Inventor score
Files withSYROS PHARMACEUTICALS INC10
Top patents by PatentIndex Score
10 records- 0190US9868994B2Methods of stratifying patients for treatment with retinoic acid receptor-α agonistsSYROS PHARMACEUTICALS INC·Filed 2017·Granted Jan 16, 2018·6 cites·22 claims
- 0286US10697025B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 30, 2020·3 cites·27 claims
- 0384US10240210B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2017·Granted Mar 26, 2019·2 cites·27 claims
- 0481US9845508B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2016·Granted Dec 19, 2017·4 cites·7 claims
- 0580US11053552B2Methods of stratifying patients for treatment with retinoic acid receptor-α agonistsSYROS PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·1 cites·22 claims
- 0680US10167518B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2017·Granted Jan 1, 2019·3 cites·7 claims
- 0774US2023042181A1Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0869US2021285059A1Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0967US11447831B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·0 cites·27 claims
- 1061US2024102106A1Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →